BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33262612)

  • 1. Berberine Inhibits Cell Proliferation by Interfering with Wild-Type and Mutant P53 in Human Glioma Cells.
    Liu Z; Chen Y; Gao H; Xu W; Zhang C; Lai J; Liu X; Sun Y; Huang H
    Onco Targets Ther; 2020; 13():12151-12162. PubMed ID: 33262612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Long Form of CAPON Overexpression on Glioma Cell Proliferation are Dependent on AKT/mTOR/P53 Signaling.
    Liang D; Song Y; Fan G; Ji D; Zhang T; Nie E; Liu X; Liang J; Yu R; Gao S
    Int J Med Sci; 2019; 16(4):614-622. PubMed ID: 31171914
    [No Abstract]   [Full Text] [Related]  

  • 3. Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities.
    Iyer SV; Parrales A; Begani P; Narkar A; Adhikari AS; Martinez LA; Iwakuma T
    Oncotarget; 2016 Feb; 7(5):5401-15. PubMed ID: 26700961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer efficacy of hirsuteine against colorectal cancer by opposite modulation of wild-type and mutant p53.
    Zhang Y; Guo T; Li S; Ren Z; Gao S; Lu H; Ma X; Liu D; Liu Y; Kong D; Qiu Y
    Discov Oncol; 2023 May; 14(1):84. PubMed ID: 37256374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical effects of honokiol on treating glioblastoma multiforme via G1 phase arrest and cell apoptosis.
    Lin CJ; Chang YA; Lin YL; Liu SH; Chang CK; Chen RM
    Phytomedicine; 2016 May; 23(5):517-27. PubMed ID: 27064011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.
    Zheng F; Tang Q; Wu J; Zhao S; Liang Z; Li L; Wu W; Hann S
    J Exp Clin Cancer Res; 2014 Apr; 33(1):36. PubMed ID: 24766860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis.
    Gomez-Manzano C; Fueyo J; Kyritsis AP; McDonnell TJ; Steck PA; Levin VA; Yung WK
    J Natl Cancer Inst; 1997 Jul; 89(14):1036-44. PubMed ID: 9230885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53-R273H Sustains ROS, Pro-Inflammatory Cytokine Release and mTOR Activation While Reducing Autophagy, Mitophagy and UCP2 Expression, Effects Prevented by wtp53.
    Romeo MA; Gilardini Montani MS; Benedetti R; Arena A; D'Orazi G; Cirone M
    Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33668399
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of cooperation of tumor suppressor p33(ING1b) with p53 gene in hepatocellular carcinoma].
    Zhu Z; Lin J; Qu JH; Li FM; Ni CR; Zhu MH
    Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1795-800. PubMed ID: 14642087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a druggable protein-protein interaction site between mutant p53 and its stabilizing chaperone DNAJA1.
    Tong X; Xu D; Mishra RK; Jones RD; Sun L; Schiltz GE; Liao J; Yang GY
    J Biol Chem; 2021; 296():100098. PubMed ID: 33208462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells.
    Ghaleb A; Padellan M; Marchenko N
    Breast Cancer Res; 2020 Dec; 22(1):133. PubMed ID: 33267874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-asarone inhibited cell growth and promoted autophagy via P53/Bcl-2/Bclin-1 and P53/AMPK/mTOR pathways in Human Glioma U251 cells.
    Wang N; Zhang Q; Luo L; Ning B; Fang Y
    J Cell Physiol; 2018 Mar; 233(3):2434-2443. PubMed ID: 28776671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WTp53 induction does not override MTp53 chemoresistance and radioresistance due to gain-of-function in lung cancer cells.
    Cuddihy AR; Jalali F; Coackley C; Bristow RG
    Mol Cancer Ther; 2008 Apr; 7(4):980-92. PubMed ID: 18413811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 status.
    Patyka M; Sharifi Z; Petrecca K; Mansure J; Jean-Claude B; Sabri S
    Oncotarget; 2016 Sep; 7(37):60245-60269. PubMed ID: 27533246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated mutant p53 promotes cancer cell survival upon glutamine deprivation through p21 induction.
    Tran TQ; Lowman XH; Reid MA; Mendez-Dorantes C; Pan M; Yang Y; Kong M
    Oncogene; 2017 Apr; 36(14):1991-2001. PubMed ID: 27721412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-Dihydroxyvitamin D
    Li M; Li L; Zhang L; Hu W; Shen J; Xiao Z; Wu X; Chan FL; Cho CH
    Life Sci; 2017 Jun; 179():88-97. PubMed ID: 28465245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of the long non-coding RNA HOTTIP inhibits glioma cell growth by BRE.
    Xu LM; Chen L; Li F; Zhang R; Li ZY; Chen FF; Jiang XD
    J Exp Clin Cancer Res; 2016 Oct; 35(1):162. PubMed ID: 27733185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of G₂/M Arrest by Berberine via Activation of PI3K/Akt and p38 in Human Chondrosarcoma Cell Line.
    Eo SH; Kim JH; Kim SJ
    Oncol Res; 2014; 22(3):147-57. PubMed ID: 26168133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of B cell CLL/Lymphoma 11B Gene Expression Represses Glioma Cell Growth.
    Liao CK; Fang KM; Chai K; Wu CH; Ho CH; Yang CS; Tzeng SF
    Mol Neurobiol; 2016 Aug; 53(6):3528-3539. PubMed ID: 26096706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
    Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
    Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.